Citadel Advisors
ADVB

Citadel Advisors’s Advanced Biomed Inc ADVB Stock Holding History

Citadel Advisors’s Portfolio ADVB Stock Details ADVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,976
Closed -$62.5K – 14568
2025
Q3 		$62.5K Buy
6,976
+4,093
+142% +$42.4K ﹤0.01% 12085
2025
Q2 		$40.4K Buy
2,883
+2,322
+414% +$68.4K ﹤0.01% 11877
2025
Q1 		$44.7K Buy
+561
New +$42.4K ﹤0.01% 12424

Other funds holding ADVB

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's ADVB Position: Q4 2025 in Review

Citadel Advisors sold out of Advanced Biomed Inc (ADVB) in Q4 2025, closing a stake of 6,976 shares — an estimated $62.5K sold.

Citadel Advisors first reported a position in ADVB in Q1 2025 and held it in 3 quarters. The position peaked at $62.5K in Q3 2025. 3 funds tracked by Wall St. Rank hold ADVB as of Q4 2025.

  • Citadel Advisors reported no remaining Advanced Biomed Inc position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 6,976 Advanced Biomed Inc shares in Q4 2025, an estimated $62.5K.
  • Citadel Advisors first reported a position in Advanced Biomed Inc in Q1 2025 and held it in 3 quarters.
  • Citadel Advisors's Advanced Biomed Inc position peaked at $62.5K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Advanced Biomed Inc as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.